A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study

Christine M. Bestvina, Kelli B. Pointer, Theodore Karrison, Hania Al-Hallaq, Philip C. Hoffman, Michael J. Jelinek, Aditya Juloori, James M. Melotek, Septimiu Murgu, Julien Partouche, Everett E. Vokes, Ralph R. Weichselbaum, Sean P. Pitroda, Jyoti D. Patel, Steven J. Chmura*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study'. Together they form a unique fingerprint.

Medicine & Life Sciences